Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Visa bets on cheaper tech and consumer choice to take on the UPI juggernaut
UPI’s share of India’s digital payments volume rose to 84% in 2025, but the global payments major believes it can stay competitive by benchmarking merchant pricing against domestic rivals and tweaking its unit economics if needed, a top Visa India executive told Mint.
PM Modi’s Ujjwala at 10 marks shift from access to empowerment, says education minister Dharmendra Pradhan
Ten years on, the Pradhan Mantri Ujjwala Yojana has provided clean cooking fuel to over 10 crore women. This initiative has significantly improved household health and reduced time spent on fuel collection. Women are now participating more in economic activities, gaining a stronger voice.
Where to invest now: SBI MF prefers large caps, pharma, PSU banks
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may outperform in the near term due to stronger loan growth, but asset quality risks could emerge over the next 2–3 quarters if global disruptions persist.
Sensex dives 850 pts, Nifty slips below 24,200 amid oil shock and weak global cues
The equity benchmark indices Sensex and Nifty tumbled on Thursday, extending losses for a second straight session. Firm crude oil prices and ongoing geopolitical tensions rattled sentiment. Brent crude surged for the fourth consecutive day to around $103 per barrel amid uncertainty over US-Iran talks and fresh concerns around the Strait of Hormuz. Weak Asian cues and persistent foreign fund outflows deepened the sell-off. The Nifty slipped below the 24,200 mark, dragged by auto, PSU banks and consumer durables stocks, while pharma and healthcare shares saw selective buying. Investors stayed cautious, closely tracking the ongoing Q4 earnings season for further triggers.
Jio, Allianz form 50-50 joint venture to set up non-life insurance company
The partnership will harness Jio’s massive digital reach and Allianz’s global expertise to build a ‘new model’ for general and health insurance in India, the two companies said on Wednesday.
Allianz, Jio Financial Services ink 50:50 insurance JV to tap India’s growing market
Jio Financial Services and Allianz Group are partnering to launch a new insurance venture in India. This 50:50 joint venture will offer general and health insurance solutions. It combines Jio's digital reach with Allianz's global insurance expertise. The venture aims to expand insurance access for individuals and businesses. Operations will commence after regulatory approvals.
INR recovers on falling oil prices amid hopes of truce in West Asia
The Indian rupee strengthened by 20 paise to settle at 93.10 (provisional) against the US dollar on Thursday, following a decline in global crude oil prices amid hopes of a truce in West Asia. Dollar pull back to seven week low also supported gains in the counter. However, sustained outflow of foreign capital amid increased dollar demand from importers capped the gain in the local currency. Indian stocks turned weak on Thursday as investors chose to take some profits, cashing in recent gains. Stocks climbed higher early on in the session amid hopes U.S. and Iran will agree on a peace deal later this week. At the interbank foreign exchange market, the rupee opened at 93.29 and touched an intraday high of 93.16 against the greenback. It also fell to the day's low of 93.35.
NCLEX-RN explained: What has changed and why it matters for Indian nurses
The NCLEX-RN exam, a crucial step for Indian nurses seeking overseas careers, has adopted a new format emphasizing clinical judgment and real-world application. This shift, particularly impacting Kerala's nursing talent, requires a move from rote memorization to conceptual understanding and practical problem-solving, aligning preparation with global healthcare demands.
Infosys names Grand Slam Champion Carlos Alcaraz as global brand ambassador
Infosys signs multi year deal with tennis star Carlos Alcaraz as global brand ambassador, to co develop AI match analytics, performance app and social impact tech projects.
US market outlook stable; India to gain from supply chain shift: Oppenheimer Asset Management
John Stoltzfus, MD and Chief Investment Strategist, Oppenheimer Asset Management, said that over the medium term, diversification of global supply chains and sectoral strengths in technology, healthcare, and manufacturing are expected to support growth across regions, including a potential recovery in India’s relative performance.
IMF Chief Says Global Prices Will Take Time to Recede After War
"It will take some time, yes, and it will take more time for locations that are experiencing higher degree of disruption," Georgieva said in comments aired Sunday on CBS's Face the Nation ahead of this week's spring meetings of the IMF and the World Bank.
Sun Pharma shares tumble 4% as firm closes in on $12-billion Organon acquisition. What’s spooking investors?
Shares of Sun Pharmaceutical Industries fell sharply after ET reported the company had submitted a $12-billion binding offer for Organon & Co. Investors remain cautious as the pharma major nears its biggest-ever overseas acquisition amid debt concerns and volatile global conditions.